State-run pharmaceutical firm Bio Farma will begin phase three of clinical trials in humans this week using a vaccine produced by China's Sinovac. If those are successful, Bio Farma has said would produce the vaccine itself. Erick Thohir, Indonesia's minister for state-owned enterprises, said Bio Farma would raise capacity in the coming months and by year-end would be ready to produce 250 million doses a year. Don't doubt Bio Farma which has been proven, either to produce vaccines that are produced with international partners or vaccines produced solely by (them)," Thohir said in a statement. Bambang Heriyanto, corporate secretary at Bio Farma, told Reuters the targeted production capacity to 250 million doses was contingent on the vaccine passing the trial.

Source: bd News24 August 04, 2020 13:30 UTC